ENFN Live-Signale | Maximieren Sie Profite mit Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Mai 2024 @ 22:00):

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific...

Stats
Tagesvolumen	226 826
Durchschnittsvolumen	422 770
Marktkapitalisierung	855.57M
EPS	$0 ( 2024-03-12 )
Nächstes Ertragsdatum	( $0.0400 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	136.00
ATR14	$0.00800 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-05	Movchan Oleg	Buy	149 701	Class A Common Stock
2024-03-05	Movchan Oleg	Buy	100 000	Class A Common Stock
2024-03-01	Movchan Oleg	Buy	13 887	Class A Common Stock
2024-03-01	Movchan Oleg	Sell	4 069	Class A Common Stock
2024-03-01	Pawar Neal	Buy	144 176	Class A Common Stock

INSIDER POWER
10.70
Last 99 transactions
Buy: 4 242 931 \| Sell: 3 488 116

Volumen Korrelation

Lang: -0.19 (neutral)

Kurz: 0.71 (moderate)

Signal:(63.817) Neutral

Enfusion, Inc. Korrelation

10 Am meisten positiv korreliert

10 Am meisten negativ korreliert

Wussten Sie das?

Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).

Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.

Enfusion, Inc. Korrelation - Währung/Rohstoff

0.75
( moderate )

0.80
( moderate )

0.00
( neutral )

0.78
( moderate )

-0.04
( neutral )

-0.79
( moderate negative )

Enfusion, Inc. Finanzdaten

Annual	2023
Umsatz:	$174.54M
Bruttogewinn:	$116.89M (66.97 %)
EPS:	$0.0718

FY	2023
Umsatz:	$174.54M
Bruttogewinn:	$116.89M (66.97 %)
EPS:	$0.0718

FY	2022
Umsatz:	$150.35M
Bruttogewinn:	$103.25M (68.67 %)
EPS:	$-0.160

FY	2021
Umsatz:	$111.70M
Bruttogewinn:	$79.86M (71.49 %)
EPS:	$-4.41

Financial Reports:

No articles found.

Enfusion, Inc.

Enfusion, Inc. provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It provides portfolio management system, which generates a real-time investment book of record that consists of valuation and risk tools that allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and order and execution management system that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines. The company also offers accounting/general ledger system, a real-time accounting book of record for chief financial officers, chief operating officers, accountants, and operations teams; Enfusion analytics system, which enables CIOs, portfolio managers, traders, and analysts to analyze portfolios through time horizons and automate customized visualized reports for internal and external stakeholders; and technology-powered and managed services. Enfusion Inc. was incorporated in 2021 and is headquartered in Chicago, Illinois.